Trial intelligence / Profile preview

Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients

NCT04409886Phase 4Terminated

Sponsor
Maimonides Medical Center
Start
Jun 2020
Primary completion
Jan 2021
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Maimonides Medical Center. Primary endpoint: Oxygenation Index. Started Jun 2020; status: terminated.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04409886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04409886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call